Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
about
Monitoring subcellular biotransformation of N-L-leucyldoxorubicin by micellar electrokinetic capillary chromatography coupled to laser-induced fluorescence detection.Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis.ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem.Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration.Synthesis, Characterization and DFT Calculations of 4,5,12- and 1,8,12-trichloro-9,10-dihydro-9,10-ethanoanthracene-12-carbonitriles
P2860
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
description
1986 nî lūn-bûn
@nan
1986 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@ast
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@en
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@nl
type
label
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@ast
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@en
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@nl
prefLabel
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@ast
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@en
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@nl
P2093
P2860
P1476
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1986.TB02942.X
P577
1986-09-01T00:00:00Z